Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2013; 19(48): 9366-9376
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9366
Table 1 Gene specific primers for polymerase chain reaction amplification and dissociation analysis
GeneForward primerReverse primer
MCP1-2518TTTCTTGACAGAGCAGAAGTGGGAGTTGCTGGCTGAGTGTTCACATAGG
CCR2 190ATACCAACGAGAGCGGTGAAGAAGAAAGCAGATCAGAGATGGCCAGG
IL10-592AAAGGAGCCTGGAACACATCCTGTAAAGTTCCCAAGCAGCCCTTCCAT
IL10-1082TCCAAGACAACACTACTAAGGCTTCGCTGGATAGGAGGTCCCTTACTTT
TGF-βCTACCGCTGCTGTGGCTACTGGTTCACCAGCTCCATGTCGATAGTCT
TLR4-299CCGATTAGCATACTTAGACTACTACCTCCCTTTCAATAGTCACACTCACCAGG
TLR4-399GCTTGAGTTTCAAAGGTTGCTGTTCTCGCCCAAGAAGTTTGAACTCATGGTAA
hOGG1ACCCTCCTACAGGTGCTGTTCAGTCCTTTGGAACCCTTTCTGCGCTTT
Table 2 Polymerase chain reaction profiles for candidate gene high resolution melt analysis
GeneAnnealing temperatureExtension temperatureMelt analysis range
MCP-158 °C72 °C74 to 84 °C
CCR-258 °C72 °C74 to 84 °C
IL10-59257 °C72 °C75 to 85 °C
IL10-108259 °C72 °C70 to 81 °C
TGF-β65 °C (20 s)72 °C (20 s)79 to 89 °C
TLR4 29957 °C68 °C66 to 78 °C
TLR4 39958 °C70 °C69 to 81 °C
hOGG157 °C68 °C78 to 88 °C
Table 3 Patient characteristics grouped according to the presence or absence of hepatic fibrosis (univariate analysis) n (%)
ParameterNo fibrosis (n = 136)Fibrosis present (n = 109)P value
Male gender72 (53)89 (82)0.0001
Age at biopsy (yr) (mean ± SD)39.7 (14.9)44.3 (12.4)0.006
Alcohol (g/d) (median: range)5 (0-120)20 (0-200)0.0001
Steatosis present136 (37)42 (53)0.03
Serum ferritin (μg/L) (median: range)531 (33-3000)2134 (155-6000)0.0001
HIC (μmol/g dw) (median: range)124 (20-537)218 (43-847)< 0.0001
Iron grade
01 (1)0
15 (4)0
227 (20)7 (6)
363 (46)25 (23)
440 (29)77 (71)< 0.0001
Table 4 Allele frequency in candidate genes assessed in patient and control groups by high resolution melt analysis: Compared to published data for Caucasian ethnicity populations
GenePatient groupControl groupPublished results1
MCP1A 0.729A 0.736A 0.695
G 0.271G 0.264G0.305
CCR2G 0.892G 0.976G 0.892
A 0.108A 0.024A 0.108
TGFβG 0.918G 0.892G 0.887
C 0.082C 0.108C 0.113
hOGG1C 0.695C 0.694C 0.776
G 0.305G 0.306G 0.224
IL10-1082G 0.539G 0.500G0.531
A 0.461A 0.500A 0.469
IL10-592C 0.794C 0.794C 0.792
A 0.206A 0.206A 0.208
TLR4 299A 0.934A 0.930A 0.967
G 0.066G 0.070G 0.033
TLR4 399C 0.934C 0.931C 0.955
T 0.066T 0.069T 0.045
Table 5 Genetic polymorphisms in Hereditary Haemochromatosis patients grouped according the presence or absence of advanced fibrosis and subjected to univariate analysis n (%)
GeneNo/minimal fibrosis (F0-2)Advanced fibrosis (F3-4)P value
MCP1
AA99 (53.5)28 (46.7)
AG76 (41.1)27 (45.0)
GG10 (5.4)5 (8.3)0.546
CCR2
GG142 (78.0)50 (84.8)
AG37 (20.3)9 (15.3)
AA3 (1.7)0 (0)0.401
TGFβ
GG154 (83.2)51 (85)
GC31 (16.8)9 (15)0.749
hOGG1
CC99 (53.8)26 (43.3)
CG64 (34.8)25 (41.7)
GG21 (11.4)9 (15)0.352
IL10-1082
GG50 (27.1)17 (28.3)
GA97 (52.4)33 (55.0)
AA38 (20.5)10 (16.7)0.806
IL10-592
CC120 (64.9)37 (61.7)
AC58 (31.3)17 (28.3)
AA7 (3.8)6 (10.0)0.173
TLR4 299
AA159 (86.4)54 (91.5)
AG24 (13.0)4 (6.8)
GG1 (0.6)1 (1.7)0.305
TLR4 399
CC161 (87.0)53 (89.8)
CT23 (12.4)5 (8.5)
TT1 (0.5)1 (1.7)0.502
Table 6 Multivariate ordered logistic regression analysis determining role of genetic polymorphisms in increasing hepatic fibrosis stage
GeneOR95%CIP valueAdjusted P value1
MCP11.110.69-1.800.6600.681
CCR20.710.36-1.320.2840.432
TGFβ1.030.54-1.950.9360.740
hOGG10.940.44-1.980.8640.588
IL10-10821.100.65-1.880.7200.897
IL10-5920.820.50-1.350.4410.639
TLR4 2990.730.35-1.530.4030.745
TLR4 3990.870.42-1.810.7060.990
Table 7 Genetic polymorphism frequencies in patients with heavy iron loading (Grade 3 and 4) grouped according to no fibrosis (F0) vs advanced fibrosis (F3/F4)
GeneNo fibrosis (F0) (n = 103)Advanced fibrosis (F3/4) (n = 60)P valueAdjusted P value1
MCP1AA 53/103AG/GGAA 28/60AG/GG 32/600.5550.433
51.50%50/103 48.5%46.70%53.3%
CCR2GG 81/100AG/AAGG 50/59AG/AA 9/590.5490.277
81%19/100 19%84.70%15.3%
TGF βGG 86/103CG/CC 17/103GG 51/60CG/CC 9/600.8000.968
83.50%16.5%85%15%
hOGG1CC 54/102CG/GG 48/102CC 26/60CG/GG 34/600.2380.790
52.90%47.1%43.30%56.7%
IL10-1082AA/AG 75/103GG 28/103AA/AG 43/60GG 17/600.8740.998
72.8%27.20%71.80%28.30%
IL10-592AA/AC 34/103CC 66/103AA/AC 23/60CC 37/600.4920.659
33.0%67.0%38.3%61.7%
TLR4 299AA 87/102AG/GG 15/102AA 54/59AG/GG 5/590.2480.848
85.3%14.7%91.5%8.5%
TLR4 399CC 89/103CT/TT 14/103CC 53/59CT/TT 6/590.5240.985
86.4%13.6%89.8%10.2%
Table 8 Logistic regression analysis performed in subjects with HIC > 236 μmol/g dw and comparing outcome of F0 vs F3/4 (univariate analysis) (n = 47)
FactorOR95%CIP value
Age1.071.00-1.150.034
Alcohol1.031.01-1.050.011
Female gender0.270.05-1.550.140
MCP11.200.37-3.870.76
CCR20.740.13-4.120.73
TGFβ0.580.09-3.520.553
hOGG11.500.47-4.770.492
IL10-10821.890.48-7.440.363
IL10-5920.980.30-3.210.980
TLR4 2991.170.77-7.790.868
TLR4 3991.240.19-8.190.824